NO20076515L - Hydantoinforbindelser - Google Patents

Hydantoinforbindelser

Info

Publication number
NO20076515L
NO20076515L NO20076515A NO20076515A NO20076515L NO 20076515 L NO20076515 L NO 20076515L NO 20076515 A NO20076515 A NO 20076515A NO 20076515 A NO20076515 A NO 20076515A NO 20076515 L NO20076515 L NO 20076515L
Authority
NO
Norway
Prior art keywords
hydantoin
treating
useful
formula
relates
Prior art date
Application number
NO20076515A
Other languages
English (en)
Norwegian (no)
Inventor
Mark Spyvee
Shawn Schiller
Eric Carlson
Qian Chen
Heather Davis
Jr Brian M Gallagher
Christina Shaffer
Nancy Wong
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO20076515L publication Critical patent/NO20076515L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20076515A 2005-05-27 2007-12-19 Hydantoinforbindelser NO20076515L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68559405P 2005-05-27 2005-05-27
PCT/US2006/020848 WO2006128143A2 (fr) 2005-05-27 2006-05-26 Composes a base d'hydantoine

Publications (1)

Publication Number Publication Date
NO20076515L true NO20076515L (no) 2007-12-19

Family

ID=37189015

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076515A NO20076515L (no) 2005-05-27 2007-12-19 Hydantoinforbindelser

Country Status (15)

Country Link
US (2) US7666875B2 (fr)
EP (2) EP2336131A1 (fr)
JP (1) JP2008542304A (fr)
KR (1) KR20080013931A (fr)
CN (1) CN101263141A (fr)
AU (1) AU2006251947A1 (fr)
BR (1) BRPI0609895A2 (fr)
CA (1) CA2609270A1 (fr)
DE (1) DE06771541T1 (fr)
IL (1) IL187279A0 (fr)
MX (1) MX2007014888A (fr)
NO (1) NO20076515L (fr)
RU (1) RU2007149327A (fr)
TW (1) TW200724140A (fr)
WO (1) WO2006128143A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds
ATE474574T1 (de) 2006-05-26 2010-08-15 Eisai R&D Man Co Ltd Imidazoazephinonverbindungen
KR20090029703A (ko) * 2006-05-26 2009-03-23 에자이 알앤드디 매니지먼트 가부시키가이샤 이미다조아제피논 화합물
WO2007139948A2 (fr) * 2006-05-26 2007-12-06 Eisai R & D Management Co., Ltd Composés d'imidazo-azépinone
AU2007293416A1 (en) * 2006-09-07 2008-03-13 Merck & Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
WO2009064431A1 (fr) * 2007-11-15 2009-05-22 Eisai E & D Management Co., Ltd. Procédés d'utilisation
KR20100088695A (ko) * 2007-11-15 2010-08-10 에자이 알앤드디 매니지먼트 가부시키가이샤 거울상 이성질체가 강화된 이미다조아제피논 화합물
US20110065916A1 (en) * 2007-11-26 2011-03-17 Mark Spyvee Method of making imidazoazepinone compounds
ES2879351T3 (es) 2016-02-25 2021-11-22 Asceneuron Sa Sales de derivados de piperazina obtenidas por adición de ácidos
EP3419971B1 (fr) 2016-02-25 2022-04-20 Asceneuron SA Inhibiteurs de glycosidases
WO2020039028A1 (fr) 2018-08-22 2020-02-27 Asceneuron S. A. Inhibiteurs de tétrahydro-benzoazépine glycosidase
WO2020039029A1 (fr) * 2018-08-22 2020-02-27 Asceneuron S. A. Composés spiro utilisés en tant qu'inhibiteurs de glycosidases
US12016852B2 (en) 2018-08-22 2024-06-25 Asceneuron Sa Pyrrolidine glycosidase inhibitors
WO2024092040A1 (fr) * 2022-10-26 2024-05-02 Protego Biopharma, Inc. Composés hétéroaryle bicycliques contenant un spirocycle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US685594A (en) 1901-04-19 1901-10-29 Frank A Franklin Pulp-washing machine.
US7498323B2 (en) * 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
EP1786816A4 (fr) * 2003-09-10 2009-11-04 Virochem Pharma Inc Composes de spirohydantoine et procedes de modulation de l'activite des recepteurs de chimiokine
US7709642B2 (en) * 2004-06-25 2010-05-04 Virochem Pharma, Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds

Also Published As

Publication number Publication date
US20060270696A1 (en) 2006-11-30
US20100113446A1 (en) 2010-05-06
CN101263141A (zh) 2008-09-10
EP1888583A2 (fr) 2008-02-20
IL187279A0 (en) 2008-02-09
DE06771541T1 (de) 2008-09-11
MX2007014888A (es) 2008-02-19
EP2336131A1 (fr) 2011-06-22
AU2006251947A1 (en) 2006-11-30
US7666875B2 (en) 2010-02-23
JP2008542304A (ja) 2008-11-27
CA2609270A1 (fr) 2006-11-30
WO2006128143A3 (fr) 2007-03-29
WO2006128143A2 (fr) 2006-11-30
KR20080013931A (ko) 2008-02-13
RU2007149327A (ru) 2009-07-10
BRPI0609895A2 (pt) 2011-10-11
TW200724140A (en) 2007-07-01

Similar Documents

Publication Publication Date Title
NO20076515L (no) Hydantoinforbindelser
EA201070423A1 (ru) Диарильные соединения оксадиазолов
NO20081421L (no) Midler for hindring og behandling av forstyrrelser som involverer modulering av RYR-reseptorer
NO20070933L (no) Indazoler anvendbare i behandling av kardiovaskulaere sykdommer
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
EA201070238A1 (ru) Соединения пиримидина
NO20070489L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
WO2007008704A3 (fr) Ligands des recepteurs de la melanocortine
NO20075099L (no) Alkynyl-pyrrolopyrmidiner og relaterte analoger som HSP90-inhibitorer
NO20084489L (no) Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet
WO2007079214A3 (fr) Antagonistes du recepteur de la prokineticine 2
HK1188985A1 (zh) 治療細胞增殖紊亂的化合物和方法
TW200714604A (en) Substituted heterocycles and the uses thereof
WO2007070434A3 (fr) Amino-piperidines fusionnees en tant qu'inhibiteurs de la dipeptidyl peptidase-4 pour le traitement ou la prevention du diabete
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
NO20076059L (no) 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer
NO20074941L (no) Anvendelse av diosmetinforbindelser i behandlingen og forebyggingen av trombotiske patologier
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
DK2358717T3 (da) Aminotetrahydropyraner som dipeptidylpeptidase-iv-inhibitorer tilbehandling eller forebyggelse af diabetes
JO2747B1 (en) Vehicles
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
SE0403006D0 (sv) New compounds
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
EA201000550A1 (ru) Производные тиазола

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application